Balancing Bleeding and Clotting Risks: Updated LP Guidelines in Antithrombotic Care- by Dr. Chokri Ben Lamines
Updated Peri-Procedural Guidelines at a Glance on X։
Explore Dr. Chokri Ben Lamine’s evidence-based guide on safely performing lumbar puncture in patients receiving anticoagulants or antiplatelet therapy. This concise reference outlines when to pause, bridge, or proceed—based on the latest international recommendations․
“Lumbar Puncture & Bleeding Risk: Summary
-When to stop or continue common agents (aspirin, warfarin, DOACs)
-Risk stratification for bleeding vs. thrombosis
-Bridging protocols for high-risk patients
-Practical timing for safe LP executionStop Antithrombotics Before LP
Antiplatelets
• Aspirin 75mg: Continue
• Clopidogrel: 7d (aspirin cover) → LP after 6h
• Prasugrel/Ticagrelor: 7d → LP after 6h
• Dipyridamole: 24h → LP after 6h
• Tirofiban/Eptifibatide: 4–8h → LP after 4h
• Abciximab: 48h → LP after 24hAnticoagulants
• Warfarin: 5d → INR ≤1.4 → LP → restart 12h
• LMWH (proph): 12h → LP → restart 4h
• LMWH (Tx): 24h → LP → restart 4h (24h if traumatic)
• Fondaparinux (proph): 36h → LP → restart 6–12h
• Fondaparinux (Tx): Avoid LP
• UFH IV: –6h → LP → restart 1h
• Rivaroxaban/Apixaban: 24h → LP → restart 6h
• Dabigatran: 48h → LP → restart 6h”
For fast answers to nuanced clinical questions, visit Hemostasis Today.
-
Aug 4, 2025, 06:00Genotype–Phenotype Understanding in Hemophilia B: Commentary on Factor IX Missense Variants
-
Aug 4, 2025, 05:47National Health Center Week – Recognizing the Vital Role of HTCs in Specialized Care
-
Aug 4, 2025, 05:33Women with Hemophilia Finally Heard: “DISMISSED” Premieres August 22
-
Aug 4, 2025, 04:58Women with Inherited Bleeding Disorders: Overcoming Diagnostic and Clinical Challenge
-
Aug 4, 2025, 01:37EAHAD Launches Italian Booklet to Support Young Girls With Bleeding Disorders During Their First Period
-
Aug 4, 2025, 01:59Michael Makris Posts Haemophilia Journal Article Reassessing UK Blood Inquiry
-
Aug 4, 2025, 01:09Manuel Monreal Congratulates Authors Ahead of JTH Publication: VTE-Predict Score Validated in RIETE Cohort
-
Aug 3, 2025, 17:48Nathan Connell: What Is The "Mild Equivalent" For Hemophilia A That Is Achieved While on Emicizumab?
-
Aug 3, 2025, 03:54Cedric Hermans on the Inspiring Impact of the WFH Humanitarian Aid Program Worldwide
-
Aug 2, 2025, 20:14Sebastian Szmit Shares Patients’ Perspectives on Decision‑Making for Antithrombotic Therapy in Advanced Cancer
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 4, 2025, 05:20NBCA: Alexis’s DVT Diagnosis Came Without Warning - Learn How She Caught It Early
-
Aug 4, 2025, 00:50NBCA: After Losing Her Daughter to a Blood Clot, Charita Fights to Save Others
-
Aug 3, 2025, 18:10Andrew Agwunobi Congrats Dr. Oladipo Cole and The Whole Team at the Connecticut Bleeding Disorder Center
-
Aug 3, 2025, 12:03Elias Bouchi Presents Werfen EEMEA Talks on Hemostasis: Clot Stories Season 3
-
Jul 31, 2025, 15:37Sano Genetics: “Unreasonable” Leadership with Benny Sorenson of Hemab